Quoin Pharmaceuticals, Ltd. ($QNRX)
Filing Information
| Accession Number | 0001104659-26-104403 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,366
Total Value
$49,990.72
P&L
+33.4% (+$16,697.72)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | ADSs | โ | Aug 31, 2026 | Purchase | 10,244 | $4.88 | $49,990.72 | 10,684 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Warrants (Right to Buy) | Derivative | Aug 31, 2026 | Purchase | 5,122 | โ | โ | 5,122 | Direct | โ | View Details |